315 results on '"Pontikoglou, Charalampos"'
Search Results
2. A Comparative Sentiment Analysis of Greek Clinical Conversations Using BERT, RoBERTa, GPT-2, and XLNet
3. Author Correction: Iron restriction inside macrophages regulates pulmonary host defense against Rhizopus species.
4. Real world data on the prognostic significance of monocytopenia in myelodysplastic syndrome
5. Characterization of myeloid‐derived suppressor cells in the peripheral blood and bone marrow of patients with chronic idiopathic neutropenia.
6. Iron restriction inside macrophages regulates pulmonary host defense against Rhizopus species.
7. Cell Instructive Behavior of Composite Scaffolds in a Co-Culture of Human Mesenchymal Stem Cells and Peripheral Blood Mononuclear Cells
8. Increased proportion and altered properties of intermediate monocytes in the peripheral blood of patients with lower risk Myelodysplastic Syndrome
9. A Greek Conversational Agent for Hematologic Malignancies: Usability and User Experience Assessment.
10. Characteristics of Long-Term Survival in Patients With Myelodysplastic Syndrome Treated With 5-Azacyditine: Results From the Hellenic 5-Azacytidine Registry
11. Illness Perceptions and Illness Outcomes in Patients with Hematologic Diseases: A Narrative Review
12. Sentiment Analysis in Greek Clinical Conversations: A Comparative Study of BERT, VADER, and Lexicon Approaches
13. miRkit: R framework analyzing miRNA PCR array data
14. Caplacizumab for immune thrombotic thrombocytopenic purpura: real-world multicenter data
15. P752: TRANSCRIPTOMIC ANALYSIS OF MYELOID-DERIVED SUPPRESSOR CELLS (MDSCS) IN THE PERIPHERAL BLOOD OF PATIENTS WITH CHRONIC IDIOPATHIC NEUTROPENIA (CIN)
16. P1606: PRIMARY AND SECONDARY IMMUNE THROMBOCYTOPENIA (ITP) IN ADULTS: REAL WORLD COMPARATIVE RETROSPECTIVE STUDY FROM THE ITP REGISTRY OF THE HELLENIC SOCIETY OF HEMATOLOGY
17. Immunoglobulin and B-cell disturbances in patients with chronic idiopathic neutropenia
18. Recombinant human bone morphogenetic protein 2 (rhBMP-2) immobilized on laser-fabricated 3D scaffolds enhance osteogenesis
19. The prognostic significance of macrocytosis in patients with myelodysplastic neoplasms
20. Cytogenetic evaluation of mesenchymal stem/stromal cells from patients with myelodysplastic syndromes at different time-points during ex vivo expansion
21. Erythrodermic psoriasis after rituximab treatment in a patient with autoimmune hemolytic anemia
22. The mesenchymal compartment in myelodysplastic syndrome: Its role in the pathogenesis of the disorder and its therapeutic targeting
23. Circulating mesenchymal stem cells in patients with hypertrophic cardiomyopathy
24. Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura: Real-World Multicenter Data on Re-Administration and Plasma Exchange Free Treatment
25. New Perspectives on Myeloid-Derived Suppressor Cells and Their Emerging Role in Haematology
26. Chitosan/gelatin scaffolds support bone regeneration
27. Multiple Sites of Arterial Thrombosis in A 35-Year Old Patient after ChAdOx1 (AstraZeneca) Vaccination, Requiring Emergent Femoral and Carotid Surgical Thrombectomy
28. Effect of the nonpeptide thrombopoietin receptor agonist eltrombopag on megakaryopoiesis of patients with lower risk myelodysplastic syndrome
29. Follow-up Next Generation Sequencing (NGS) Analyses on Clonal Chronic Idiopathic Neutropenia (CIN) Patients: Insights in the Natural History of the Disease
30. Myelodysplastic Syndromes (MDS) Presenting with Isolated Thrombocytopenia: Characteristics, Outcomes, and Clinical Presentation Differences from Immune Thrombocytopenic Purpura (ITP)
31. Increased Frequency of Mutations in the Gene Responsible for Familial Mediterranean Fever (MEFV) in a Cohort of Patients with Chronic Idiopathic Neutropenia
32. MyPal ADULT study protocol: a randomised clinical trial of the MyPal ePRO-based early palliative care system in adult patients with haematological malignancies
33. Endothelial progenitor cells as markers of severity in hypertrophic cardiomyopathy
34. Incidence and prognosis of clonal hematopoiesis in patients with chronic idiopathic neutropenia
35. Therapeutic Implications of Mesenchymal Stromal Cells and Their Extracellular Vesicles in Autoimmune Diseases: From Biology to Clinical Applications
36. Designing a conversational agent for patients with hematologic malignancies: Usability and Usefulness Study
37. miRkit: R Framework Analyzing miRNA PCR Array Data
38. Bone Marrow Mesenchymal Stem Cells: Biological Properties and Their Role in Hematopoiesis and Hematopoietic Stem Cell Transplantation
39. Oncology and complications
40. Soluble c-kit ligand production by bone marrow stromal cells is independent of the degree of neutropenia in patients with chronic idiopathic neutropenia
41. Frequency and Functional Analysis of Myeloid-Derived Suppressor Cells (MDSCs) in the Peripheral Blood and Bone Marrow of Patients with Chronic Idiopathic Neutropenia (CIN)
42. Lymphopenia in patients with chronic idiopathic neutropenia is associated with decreased number of T-lymphocytes containing T-cell receptor excision circles
43. Pathophysiologic mechanisms and management of neutropenia associated with large granular lymphocytic leukemia
44. Osteogenic differentiation of bone marrow mesenchymal stem cells on chitosan/gelatin scaffolds: gene expression profile and mechanical analysis
45. The effect of 5‐azacytidine treatment delays and dose reductions on the prognosis of patients with myelodysplastic syndrome: how to optimize treatment results and outcomes
46. The Role of Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles (MSC-EVs) in Normal and Abnormal Hematopoiesis and Their Therapeutic Potential
47. Prognostic Significance of Bone Marrow Cellularity in the Outcome of Patients with Myelodysplastic Syndromes Treated with Azacyitidine: A Retrospective Analysis from the Hellenic MDS Study Group
48. Bone regeneration: the stem/progenitor cells point of view
49. The −509C/T polymorphism of transforming growth factor-β1 is associated with increased risk for development of chronic idiopathic neutropenia
50. Pathophysiologic mechanisms, clinical features and treatment of idiopathic neutropenia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.